Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company announced preclinical test results that showed Telomir-1 restored mitochondrial function without triggering oxidative stress or cell proliferation in human cells. This sets Telomir-1 apart from many other related treatments and opens the door to treating numerous serious conditions.
